Bloomberg BusinessweekBloomberg Businessweek

Targeting Sickle Cell Disease (Sponsored Content)

View descriptionShare
 

Terri Booker’s body burns with pain. She’s one of the 100,000 Americans living with sickle cell disease – a blood disorder that can cause severe pain, organ failure, and even premature death. The genetic condition came about to protect against malaria. Dr. William Hobbs leads clinical development for sickle cell disease at Vertex, and they are investigating multiple approaches to address the unmet needs that patients face. 

This episode of Targeting the Toughest Diseases is sponsored by Vertex Pharmaceuticals.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Businessweek

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar an 
Social links
Follow podcast
Recent clips
Browse 5,261 clip(s)